A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving Estrogens
- 9 October 1986
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 315 (15), 930-934
- https://doi.org/10.1056/nejm198610093151504
Abstract
Progestin is often added to regimens of estrogen therapy in postmenopausal women to reduce the risk of endometrial hyperstimulation, but it may cause undesirable metabolic effects. Therefore, a low dosage is recommended. At present, the only way to determine whether the dosage of progestin is causing the desired secretory transformation of the endometrium is by endometrial sampling, which is invasive.This publication has 15 references indexed in Scilit:
- Effects of dydrogesterone on the oestrogenized postmenopausal endometriumBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.BMJ, 1983
- A controlled trial of naproxen sodium for relief of pain associated with Vabra suction curettageBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1981
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- Absorption and metabolism of oral progesterone.BMJ, 1980
- Increased Risk of Endometrial Carcinoma among Users of Conjugated EstrogensNew England Journal of Medicine, 1975
- Association of Exogenous Estrogen and Endometrial CarcinomaNew England Journal of Medicine, 1975
- Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1Journal of Clinical Endocrinology & Metabolism, 1971